EditorialBiden Awards the National Medal of Science and the National Medal of Technology and Innovation, Washington, District of Columbia, USA - 24 Oct 2023
EditorialVivek Ramaswamy, a Republican presidential candidate, speaks during the Georgia GOP State Convention at the Columbus Convention and Trade Center in Columbus, Ga, June 9, 2023. (Jon Cherry/The New York Times)
EditorialVivek Ramaswamy, a Republican presidential candidate, speaks during the Georgia GOP State Convention at the Columbus Convention and Trade Center in Columbus, Ga, June 9, 2023. (Jon Cherry/The New York Times)
EditorialVivek Ramaswamy, a Republican presidential candidate, speaks during the Georgia GOP State Convention at the Columbus Convention and Trade Center in Columbus, Ga, June 9, 2023. (Jon Cherry/The New York Times)
EditorialVivek Ramaswamy, a Republican presidential candidate, speaks during the Georgia GOP State Convention at the Columbus Convention and Trade Center in Columbus, Ga, June 9, 2023. (Jon Cherry/The New York Times)
EditorialInside the labs of Afrigen Biologics and Vaccines, a Cape Town biotechnology company that has ambitions to be a major producer of new mRNA vaccines, in South Africa, Sept. 27, 2021. (Sydelle Willow Smith/The New York Times)
EditorialInside the labs of Afrigen Biologics and Vaccines, a Cape Town biotechnology company that has ambitions to be a major producer of new mRNA vaccines, in South Africa, Sept. 27, 2021. (Sydelle Willow Smith/The New York Times)
EditorialInside the labs of Afrigen Biologics and Vaccines, a Cape Town biotechnology company that has ambitions to be a major producer of new mRNA vaccines, in South Africa, Sept. 27, 2021. (Sydelle Willow Smith/The New York Times)
EditorialInside the labs of Afrigen Biologics and Vaccines, a Cape Town biotechnology company that has ambitions to be a major producer of new mRNA vaccines, in South Africa, Sept. 27, 2021. (Sydelle Willow Smith/The New York Times)
EditorialInside the labs of Afrigen Biologics and Vaccines, a Cape Town biotechnology company that has ambitions to be a major producer of new mRNA vaccines, in South Africa, Sept. 27, 2021. (Sydelle Willow Smith/The New York Times)
EditorialInside the labs of Afrigen Biologics and Vaccines, a Cape Town biotechnology company that has ambitions to be a major producer of new mRNA vaccines, in South Africa, Sept. 27, 2021. (Sydelle Willow Smith/The New York Times)
EditorialInside the labs of Afrigen Biologics and Vaccines, a Cape Town biotechnology company that has ambitions to be a major producer of new mRNA vaccines, in South Africa, Sept. 27, 2021. (Sydelle Willow Smith/The New York Times)
EditorialA nurse injects a volunteer with the Novavax Vaccine during a trial at Howard University Hospital, in Washington, on Jan. 22, 2021. (Kenny Holston/The New York Times)